Eton Pharmaceuticals Advances Its Commitment to Rare Disease With the Acquisition of Galzin®
Eton制药通过收购Galzin®进一步承诺支持罕见疾病。
Eton Pharmaceuticals Advances Its Commitment to Rare Disease With the Acquisition of Galzin®
Eton制药通过收购Galzin®进一步承诺支持罕见疾病。
译文内容由第三方软件翻译。
使用浏览器的分享功能,分享给你的好友吧